As Singapore plans for the new normal with Covid-19 as an endemic disease, top experts speak to The Straits Times' science correspondent Audrey Tan on how to live with the virus. Here are some questions answered:. Read more at straitstimes.com.
Singapore launches next phase of National Precision Medicine Programme
New national body established to further research insights, improve patient outcomes and create new economic opportunities for the biomedical technology industry.
Precision Health Research, Singapore
SINGAPORE, 7 April 2021 – Precision medicine is part of Singapore’s Research, Innovation and Enterprise (RIE) 2025 strategic goal to transform and protect the health of every Singaporean. Identified as a priority by the Ministry of Health, precision medicine aims to understand how genomic, phenotypic, lifestyle and clinical factors contribute to the health of Singaporeans. It also supports the responsible use of health data in clinical applications with the longer-term goal of addressing Singapore’s healthcare challenges in a sustainable and clinically cost-effective manner.
Singapore announces precision oncology partnership
Singapore announces precision oncology partnership 10 February 2021 | News Public sector partners will provide research expertise and insights to build infrastructure for data sharing, and Roche will provide access to genomic testing and guidance on infrastructure design and implementation
Photo Credit: Roche Singapore
Singapore Translational Cancer Consortium (STCC), National Cancer Centre Singapore (NCCS), the National University Cancer Institute, Singapore (NCIS) at the National University Hospital (NUH) and Roche announced a unique and groundbreaking partnership between public and private sector institutions in Singapore aimed at establishing a critical infrastructure to advance the adoption of personalised healthcare in Singapore. Personalised healthcare, which includes precision oncology or personalised cancer care, leverages insights from medical and genomic data to help make more precise treatment decisions